Facebook
Twitter
LinkedIn
Forward
OCD Lecture Series: Sessions I & II - September 17, 2021
This presentation will be an ONLINE VIRTUAL LIVE on September 17, 2021, from 9:00 am - 12:15 PM EST. While this activity is broadcast LIVE, the evaluation will be online until October 8, 2021. The link to attend the broadcast and download the slides will be emailed to registrants.
The views and opinions expressed by this presenter in this lecture are their own, and do not represent the views of Sheppard Pratt.
SESSION I: Cognitive-Behavioral Treatment of Pediatric Obsessive-Compulsive Disorder
This lecture will discuss the nature of pediatric Obsessive-Compulsive Disorder and evidence-based treatment. Specifically, it will describe core elements of leading psychological approaches (i.e., exposure and response prevention). It will focus on educating learners about core concepts in treatment and how to apply them in the care of children with Obsessive-Compulsive Disorder. In addition, discussion of the relevant evidence base and future clinical and research directions will be highlighted.
LEARNING OBJECTIVES
After this lecture, registrants will be able to:
- State the core components of cognitive-behavioral therapy for pediatric Obsessive-Compulsive Disorder.
- Discuss the role of family in the treatment of pediatric Obsessive-Compulsive Disorder.
- Describe the role of cognitive therapy in pediatric Obsessive-Compulsive Disorder treatment.
SESSION II: The Role of Medications in Pediatric Obsessive-Compulsive Disorder: Water Wings for Behavioral Therapy
Obsessive-Compulsive Disorder (OCD) can be a severely impairing condition but is highly responsive to specialized care. There is a substantial evidence base demonstrating the best approaches to treating OCD; therefore, it is critical that clinicians are informed of strategies that do and don’t work. While exposure-response prevention (ERP) is the gold-standard treatment for OCD, many patients cannot adequately engage in treatment without the help of pharmacotherapy. Medications can help patients be willing to begin therapy, tolerate exposures without getting overwhelmed, and move efficiently through an exposure hierarchy. Evidence shows that outcomes are significantly improved when medications are used in conjunction with ERP. While SSRIs represent the single first-line medication class, strategies for SSRI augmentation or second- and third-line approaches are more complex. The majority of patients presenting to our intensive outpatient program have not received adequate CBT or pharmacotherapeutic care. Experience with severe OCD is often limited in training and specialized education is necessary for providers to be well-equipped to effectively treat the full range of OCD manifestations.
LEARNING OBJECTIVES
After this lecture, registrants will be able to:
- Determine the need for pharmacotherapy for OCD and choose a first-line medication.
- Identify the evidence-based augmentation options when first-line treatment is insufficient.
- Appreciate and leverage the synergy between CBT and pharmacotherapy in the treatment of OCD.
Target Audience
This activity is intended for physicians, nurses, psychologists, social workers, counselors, and other mental health professionals.
SHEPPARD PRATT OCD & ANXIETY LECTURE SERIES
This series offers 9.0 contact hours.
This presentation will be an ONLINE VIRTUAL LIVE broadcast on September 17, 2021, from 9:00 AM - 12:15 PM EST. While this activity is broadcast LIVE, the evaluation will be online until October 8, 2021. The link to attend the broadcast and download the slides will be emailed to registrants.
Sessions I & II, Friday, September 17, 2021, 9:00 am – 12:15 pm, Online Broadcast
9:00 am Introduction of speaker by Jon Hershfield, MFT
9:00 am – 10:30 am Session I: Cognitive-Behavioral Treatment of Pediatric Obsessive-Compulsive Disorder - Eric A. Storch, PhD
10:30 am – 10:45 am Break
10:45 am Introduction of speaker by Jon Hershfield, MFT
10:45 am – 12:15 pm Session II: The Role of Medications in Pediatric Obsessive-Compulsive Disorder: Water Wings for Behavioral Therapy - Erika Nurmi, MD, PhD
Sessions III & IV, Friday, October 22, 2021, 9:00 am – 12:15 pm, Online Broadcast
9:00 am Introduction of speaker by Jon Hershfield, MFT
9:00 am – 10: 30 am Session III: Obsessive-Compulsive Disorder and Relationships: Helping Our Patients Thrive in Love, Friendship, and Family- Amy Mariaskin, PhD
10:30 am – 10:45 am Break
10:45 am Introduction of speaker by Jon Hershfield, MFT
10:45 am – 12:15 pm Session IV: The Treatment of Co-occurring Borderline Personality Disorder and Obsessive-Compulsive Disorder - Blaise Aguirre, MD
Sessions V & VI, Friday, November 12, 2021, 9:00 am – 12:15 pm, Online Broadcast
9:00 am Introduction of speaker by Jon Hershfield, MFT
9:00 am – 10: 30 am Session V: Effective and Respectful Treatment for Scrupulous Obsessive-Compulsive Disorder - Jedidiah Siev, PhD
10:30 am – 10:45 am Break
10:45 am Introduction of speaker by Jon Hershfield, MFT
10:45 am – 12:15 pm Session VI: Sexual Obsessions in Obsessive-Compulsive Disorder - Monnica Williams, PhD
In the event an announced speaker is unable to present, Sheppard Pratt reserves the right to present an alternative speaker on a comparable subject.
There is no commercial support for this activity.
About these speakers
Eric Storch, PhD, is Professor and McIngvale Presidential Endowed Chair in the Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine (BCM). He serves as Vice Chair and Head of Psychology, and co-directs the OCD program at BCM. Dr. Storch specializes in the nature and treatment of childhood and adult obsessive-compulsive disorder, anxiety disorders, PTSD, and anxiety among youth with autism spectrum disorder. He has received multiple grants to investigate treatment efficacy, mechanisms of action, treatment dissemination, and how to enhance outcomes for those struggling with these conditions.
Erika Nurmi, MD, PhD received her MD/PhD from Vanderbilt University and her clinical training in adult, child and adolescent psychiatry from UCLA. She is currently Associate Professor of Psychiatry and Biobehavioral Sciences in the UCLA Division of Child and Adolescent Psychiatry. In both research and clinical practice, Dr. Nurmi specializes in obsessive-compulsive and tic disorders. She is Medical Director of the Pediatric OCD Intensive Outpatient Program, a part of the UCLA Childhood OCD, Anxiety, and Tic Disorders Program. At the Greater Los Angeles VA, partner to UCLA, she is the Anxiety Disorders Section Chief. Dr. Nurmi directs a molecular and computational genetics laboratory, investigating genetic contributions to mental illness vulnerability and response to treatment. She is an executive member of the OCD/Tourette Working Group of the Psychiatric Genomics Consortium and UCLA site Principal Investigator for the International OCD ENIGMA Consortium. Dr. Nurmi is a national and international speaker in educational forums, clinician trainings, parent/patient support groups and public events, where she enjoys sharing her passion for science and medicine.
Disclosure Statements
Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.
Eric A. Storch, PhD, reports receiving book royalties from Elsevier, Wiley, Oxford, APA, Springer, Jessica Kingsley and consulting with Biohaven Pharmaceuticals, Inc., during the past 12 months. He will not discuss any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, in this presentation.
Erika Nurmi, MD, PhD, reports that she is on the Medical Advisory Board of the Tourette Association of America & Teva Pharmaceuticals and Scientific Advisory Board of Myriad Genetics. She will discuss genetic testing to inform prescribing, and off label uses of augmentation drugs & new alternatives not FDA-approved for OCD but well-supported by literature, in this presentation.
Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Todd Peters, MD, Deepak Prabhakar, MD, Briana Riemer, MD, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PhD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, and Jennifer Tornabene.
This series offers 9.0 contact hours for attending all three dates.
Physician Statement: Sheppard Pratt is accredited by The Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. Sheppard Pratt designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Statement: Sheppard Pratt is an approved provider of continuing nursing education by Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity provides 3.0 contact hours for nurses.
Psychologist Statement: Sheppard Pratt is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this continuing education activity. Sheppard Pratt designates this educational activity for a maximum of 3.0 contact hours for Psychologists.
Social Worker Statement: Sheppard Pratt is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this continuing education activity. This activity is approved for 3.0 contact hours in Category I credits for Social Workers.
Counselor Statement: Sheppard Pratt has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5098. Programs that do not qualify for NBCC credit are clearly identified. Sheppard Pratt is solely responsible for all aspects of the program. This activity is available for 3.0 NBCC clock hours.
Available Credit
- 3.00 ACEP NBCC clock hours
- 3.00 AMA PRA Category 1 Credit™
- 3.00 Category II credits for Social Workers
- 3.00 Psychologists
- 3.00 MNA Contact Hours for Nurses
- 3.00 Participation
Eric A. Storch, PhD
Professor, COPH Dean's Office
Endowed Chair, College of Medicine Pediatrics
Director of Research for Developmental Pediatrics, Pediatrics
Clinical Director, Pediatrics
Professor (Tenured), Pediatrics (Primary); Psychiatry (Joint); Psychology (Joint)
All Children's Hospital Guild Endowed Chair, Pediatrics
Houston, TX
Erika Nurmi, MD, PhD
Assistant Professor of Psychiatry and Biobehavioral Sciences
Division of Child and Adolescent Psychiatry
David Geffen School of Medicine
Medical Director, UCLA Pediatric OCD Intensive Outpatient Program
Los Angeles, CA
Price
This presentation will be an ONLINE VIRTUAL LIVE broadcast on September 17, 2021, from 9:00 AM - 12:15 PM EST. While this activity is broadcast LIVE, the evaluation will be online until October 8, 2021. The link to attend the broadcast and download the slides will be emailed to registrants.
Sessions I & II, Friday, September 17, 2021, 9:00 am – 12:15 pm, Online Broadcast
9:00 am Introduction of speaker by Jon Hershfield, MFT
9:00 am – 10:30 am Session I: Cognitive-Behavioral Treatment of Pediatric Obsessive-Compulsive Disorder - Eric A. Storch, PhD
10:30 am – 10:45 am Break
10:45 am Introduction of speaker by Jon Hershfield, MFT
10:45 am – 12:15 pm Session II: The Role of Medications in Pediatric Obsessive-Compulsive Disorder: Water Wings for Behavioral Therapy - Erika Nurmi, MD, PhD
Sessions III & IV, Friday, October 22, 2021, 9:00 am – 12:15 pm, Online Broadcast
9:00 am Introduction of speaker by Jon Hershfield, MFT
9:00 am – 10: 30 am Session III: Obsessive-Compulsive Disorder and Relationships: Helping Our Patients Thrive in Love, Friendship, and Family - Amy Mariaskin, PhD
10:30 am – 10:45 am Break
10:45 am Introduction of speaker by Jon Hershfield, MFT
10:45 am – 12:15 pm Session IV: The Treatment of Co-occurring Borderline Personality Disorder and Obsessive-Compulsive Disorder - Blaise Aguirre, MD
Sessions V & VI, Friday, November 12, 2021, 9:00 am – 12:15 pm, Online Broadcast
9:00 am Introduction of speaker by Jon Hershfield, MFT
9:00 am – 10: 30 am Session V: Effective and Respectful Treatment for Scrupulous Obsessive-Compulsive Disorder - Jedidiah Siev, PhD
10:30 am – 10:45 am Break
10:45 am Introduction of speaker by Jon Hershfield, MFT
10:45 am – 12:15 pm Session VI: Sexual Obsessions in Obsessive-Compulsive Disorder - Monnica Williams, PhD
In the event an announced speaker is unable to present, Sheppard Pratt reserves the right to present an alternative speaker on a comparable subject.
REGISTRATION FEES
General Registration: Activity fee to attend one activity $75.
EARLY BIRD: ATTEND ALL 3 ACTIVITES FOR $150, offer expires September 10, 2021
Includes all three dates: September 17th, October 22nd & November 12th, 2021 offering 9 contact hours
COMMUNITY COUPON: Add coupon code: OCD 2021 when purchasing all 3 activities
Employees of Sheppard Pratt and affiliate agencies: Activity fee to attend one activity $45.
EARLY BIRD: ATTEND ALL 3 ACTIVITES FOR $75, offer expires September 17, 2021
Includes all three dates: September 17th, October 22nd & November 12th, 2021 offering 9 contact hours
SHEPPARD PRATT COUPON: Add coupon code: SP OCD 2021 when purchasing all 3 activities
REGISTER AND MAKE PAYMENT
Payment can be made by credit card online through the Sheppard Pratt Ethos System. We accept Visa, MasterCard, American Express and Discover.
To register to earn credit for attending this activity, log into or register for an account in Sheppard Pratt’s Ethos continuing education system at https://cme.sheppardpratt.org/
Select the activity by double clicking on the title and select add to cart.
Follow the prompts until the payment and registration process is complete.
WITHDRAWAL DEADLINES & REFUND POLICY
September 10, 2021: September 10, 2021 is the deadline to request a refund for withdrawal from the EARLY BIRD and receive a refund. Withdrawals from the EARLY BIRD are subject to a $40/20 administrative charge.
No refunds or credits will be issued for request for withdrawal from the EARLY BIRD after the listed deadlines.
September 17, 2021: Friday, September 10, 2021 is the deadline to request a refund for withdrawal from the October 1st event. Withdrawals from the October 1st event are subject to a $20/$10 administrative charge.
No refunds or credits will be issued for request for withdrawal from the October 22nd event after the listed deadlines.
October 8, 2021: Friday, October 8, 2021 is the deadline to request a refund for withdrawal from the October 22nd event. Withdrawals from the October 22nd event are subject to a $20/$10 administrative charge.
No refunds or credits will be issued for request for withdrawal from the October 22nd event after the listed deadlines.
October 29, 2021: Friday, October 29, 2021 is the deadline to request a refund for withdrawal from the November 12th event. Withdrawals from the November 12th event are subject to a $20/$10 administrative charge.
No refunds or credits will be issued for request for withdrawal from the November 12th event after the listed deadlines.
WATCH THE BROADCAST AND PRINT THE HANDOUT
An email with the link to view the broadcast and handout attachments will be sent to registrants on September 16, 2021.
EARN CONTINUING EDUCATION CREDIT FOR YOUR ATTENDANCE
PRIOR TO THE EVENT: Log into your Sheppard Pratt Ethos account and register by taking the pretest. Select the activity by series, title or speaker name. Go to the last tab, REGISTER and select the GREEN RECTANGLE, TAKE COURSE, and follow the prompts. Complete the Pretest and select attendance and you will be registered for this activity. You will not be able to work further until you are marked attended by an administrator.
DURING THE EVENT: Because you will view this event online, there will not be a sign in sheet. Instead of signing in, a code word will be given during the lecture for you. There are two ways to enter the code word: by text/SMS & through the website. To use the website to enter the code word to be marked attended, you will go to https://cme.sheppardpratt.org/code and enter the code word there. To use SMS to enter the code word, you will text the code word to 410-291-8061. To save time, add this phone number to your contacts. You will have one week from the workshop date to enter the code word. Once you enter the code word, you can click on My Account > Pending Activities and you will see the course listed there. From this tab you will be able to complete your course.
AFTER THE LECTURE: Select the activity by series, title or speaker name. Select the last tab, TAKE COURSE, and select the GREEN RECTANGLE, TAKE COURSE and follow the prompts. Please use the navigation button located in the lower right corner to continue throughout the course for best results. Complete the evaluation and credit designation to earn continuing education hours or credits. Your transcript will reflect all completed events.
Questions? Look at our FAQ’s at https://cme.sheppardpratt.org/content/faq or Email cme@sheppardpratt.org
Required Hardware/software
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements
Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit
Hardware/Software Specifications
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.